BDPT — BIOADAPTIVES, INC.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1575142 ·
Last close
$0.00
Market Cap
$33.6K
52W High
$0.07
52W Low
$0.00
ADV30
23,451,640
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 4,988 | 4,240 | -197,176 | 150,090 | 78,767 | 29,221 | 1,844,874 |
| Mar 2026 | 5,514 | 4,113 | -198,218 | -111,086 | 135,949 | 73,606 | 2,272,091 |
| Dec 2025 | 10,427 | 7,583 | -248,117 | -823,346 | 225,901 | 158,445 | 2,355,957 |
| Sep 2025 | 4,632 | 3,851 | -265,689 | -379,502 | 124,360 | 59,273 | 1,589,570 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-502,958
Investing CF
$0
Financing CF
$449,115
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.09
As of
2026-08-23
Balance + Analyst (yfinance extras)
Retained Earnings
$-10,832,290
Inventory
$42,968
Receivables
$0
ST Investments
—
EBIT TTM
$-1,322,858
Pretax Income TTM
$-1,471,848
Interest Exp TTM
$148,990
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$25,561
EBITDA
$-903,200
Free Cash Flow
$-490,210
Enterprise Value
$808,724
Total Cash
$29,221
Total Debt
$522,725
Shares Out
12,008,659
Trailing EPS
$-0.11
Book Value
$-0.05
ROE
—
ROA
-323.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 18,278 | -1,042,173 | -1,557,898 | 225,901 | 2,355,957 | -2,130,056 | -516,025 |
| Dec 2024 | 12,669 | -520,740 | -899,161 | 261,885 | 1,725,803 | -1,463,918 | -249,517 |
| Dec 2023 | 28,565 | -228,921 | -712,466 | 103,998 | 1,750,629 | -1,646,631 | -223,773 |
| Dec 2022 | 17,176 | -421,900 | -895,570 | 37,314 | 1,488,815 | -1,451,501 | -227,259 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BPTH | BIO-PATH HOLDINGS, INC. | $25.1K | $0.00 | — |
| BSPK | Bespoke Extracts, Inc. | $18.0K | $0.00 | — |
| PKTX | ProtoKinetix, Inc. | $82.3K | $0.00 | — |
| OWPC | One World Products, Inc. | $96.1K | $0.00 | — |
| AVCRF | Avricore Health Inc. | $101.1K | $0.00 | — |
News headlines (Yahoo Finance, 1h cache)
BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram Video
2026-09-23 14:15 · Yahoo
UFC Hall of Famer Michael Bisping Joins BioAdaptives to Champion MyndSystem(TM)
2026-08-31 09:30 · Yahoo
BioAdaptives, Inc. Announces CEO's Share Cancellation and Provides Capital Restructure Update
2026-08-13 12:35 · Yahoo
BioAdaptives Launches XcellaraHeart With Pre-Orders Ahead of August 26 Shipments
2026-08-12 14:20 · Yahoo
BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal
2026-08-12 11:30 · Yahoo
BioAdaptives Highlights Xcellara Supply and Direction Platform for Cellular Wellness Products
2026-08-04 15:39 · Yahoo
BioAdaptives Explains the Scientific Basis of the Dual-Action Xcellara(TM) "Supply and Direction" Platform
2026-08-04 12:00 · Yahoo
BioAdaptives Opens Commercial Orders for XcellaraHeart Following Convertible Debt Retirement
2026-08-03 14:13 · Yahoo
BioAdaptives Inc. Opens Commercial Ordering Window for XcellaraHeart(TM) Cellular Wellness Formula
2026-08-03 12:00 · Yahoo
BioAdaptives Inc. Eliminates Major Market Overhang by Retiring the Debt of the Largest Convertible Commercial Investor
2026-07-30 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.